IOL Chemicals and Pharmaceuticals Limited

BSE:524164 Stock Report

Market Cap: ₹20.8b

IOL Chemicals and Pharmaceuticals Balance Sheet Health

Financial Health criteria checks 6/6

IOL Chemicals and Pharmaceuticals has a total shareholder equity of ₹16.6B and total debt of ₹1.3B, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are ₹22.7B and ₹6.1B respectively. IOL Chemicals and Pharmaceuticals's EBIT is ₹1.2B making its interest coverage ratio -22.6. It has cash and short-term investments of ₹1.5B.

Key information

7.7%

Debt to equity ratio

₹1.28b

Debt

Interest coverage ratio-22.6x
Cash₹1.54b
Equity₹16.59b
Total liabilities₹6.06b
Total assets₹22.65b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 524164's short term assets (₹10.9B) exceed its short term liabilities (₹5.3B).

Long Term Liabilities: 524164's short term assets (₹10.9B) exceed its long term liabilities (₹760.8M).


Debt to Equity History and Analysis

Debt Level: 524164 has more cash than its total debt.

Reducing Debt: 524164's debt to equity ratio has reduced from 14.7% to 7.7% over the past 5 years.

Debt Coverage: 524164's debt is well covered by operating cash flow (99.1%).

Interest Coverage: 524164 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies